166 related articles for article (PubMed ID: 2437983)
1. Tumour markers in diagnosis and management.
Warnes TW; Smith A
Baillieres Clin Gastroenterol; 1987 Jan; 1(1):63-89. PubMed ID: 2437983
[TBL] [Abstract][Full Text] [Related]
2. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of tumour marker proteins in the diagnosis of primary hepatocellular carcinoma.
Oon CJ; Yo SL; Chio LF; Chua D; Tan YO
Ann Acad Med Singap; 1980 Apr; 9(2):228-33. PubMed ID: 6158907
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
5. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours.
Brumm C; Schulze C; Charels K; Morohoshi T; Klöppel G
Histopathology; 1989 May; 14(5):503-13. PubMed ID: 2472345
[TBL] [Abstract][Full Text] [Related]
6. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Poon TC; Chan AT; Zee B; Ho SK; Mok TS; Leung TW; Johnson PJ
Oncology; 2001; 61(4):275-83. PubMed ID: 11721174
[TBL] [Abstract][Full Text] [Related]
7. Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.
Melia WM; Johnson PJ; Carter S; Munro-Neville A; Williams R
Cancer; 1981 Aug; 48(4):1004-8. PubMed ID: 6168358
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
9. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG
Oncology; 1989; 46(6):381-5. PubMed ID: 2479897
[TBL] [Abstract][Full Text] [Related]
10. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.
Johnson PJ
J Gastroenterol Hepatol; 1999 May; 14 Suppl():S32-6. PubMed ID: 10382636
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
Ferrandez-Izquierdo A; Llombart-Bosch A
Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.
Ando E; Tanaka M; Yamashita F; Kuromatsu R; Takada A; Fukumori K; Yano Y; Sumie S; Okuda K; Kumashiro R; Sata M
Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):641-8. PubMed ID: 12840676
[TBL] [Abstract][Full Text] [Related]
13. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellualar carcinoma serum markers.
Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
Sassa T; Kumada T; Nakano S; Uematsu T
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1387-92. PubMed ID: 10654799
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse
Sultanik P; Ginguay A; Vandame J; Popovici T; Meritet JF; Cynober L; Pol S; Bories PN
J Viral Hepat; 2017 Jan; 24(1):80-85. PubMed ID: 27699936
[TBL] [Abstract][Full Text] [Related]
17. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of plasma des-gamma-carboxy prothrombin as a marker protein of hepatocellular carcinoma in patients with tumors of various sizes.
Kasahara A; Hayashi N; Fusamoto H; Kawada Y; Imai Y; Yamamoto H; Hayashi E; Ogihara T; Kamada T
Dig Dis Sci; 1993 Dec; 38(12):2170-6. PubMed ID: 7505217
[TBL] [Abstract][Full Text] [Related]
19. [Carcino-fetal antigens].
Endo Y
Nihon Rinsho; 1996 Jun; 54(6):1499-504. PubMed ID: 8691600
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
